About Celea Therapeutics
Celea Therapeutics develops drug therapies for serious respiratory and fibrotic lung diseases. The company focuses on idiopathic pulmonary fibrosis (IPF) and is advancing deupirfenidone, an oral investigational therapy. Its customers are patients and physicians.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Boston, United States
Team Size
11-50
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
celeatx.com
Domain Registered Date
Aug 8, 2025
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $180,000,000 · Series-A
fundraisingfox.com
- Milestone
Website domain registered
celeatx.com
- Milestone
X account created (@CeleaTx)
8 followers
Investors & Backers
Leaps by Bayer
PureTech Health
RA Capital Management
Funding History
Series-A
· Jul 2, 2026
$180,000,000 fundraisingfox.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026